Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNF168 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAHD2CP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NAA16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCN9A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NKTR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDCD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM30A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM168A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDLIM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRCH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARSD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGGT1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMBRA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on